Sheldon L. Koenig - Dec 17, 2024 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
President and CEO, Director
Signature
/s/ Sheldon L. Koenig
Stock symbol
ESPR
Transactions as of
Dec 17, 2024
Transactions value $
-$30,694
Form type
4
Date filed
12/18/2024, 04:12 PM
Previous filing
Sep 18, 2024
Next filing
Mar 17, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ESPR Common Stock Sale -$30.7K -12.4K -1.65% $2.47 740K Dec 17, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to satisfy tax obligation on vested shares of restricted stock units.